MCM
MDT icon

Moore Capital Management’s Medtronic MDT Stock Holding History

Moore Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-50,000
Closed -$3.75M – 305
2016
Q1 		$3.75M Buy
+50,000
New +$3.77M 0.15% 144

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moore Capital Management's MDT Position: Q4 2021 in Review

Moore Capital Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 210,572 shares — an estimated $26.4M sold.

Moore Capital Management first reported a position in MDT in Q1 2015 and held it in 5 quarters. The position peaked at $28.8M in Q4 2015. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Moore Capital Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Moore Capital Management sold 210,572 Medtronic shares in Q4 2021, an estimated $26.4M.
  • Moore Capital Management first reported a position in Medtronic in Q1 2015 and held it in 5 quarters.
  • Moore Capital Management's Medtronic position peaked at $28.8M in Q4 2015.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.